Erick Lelouche is a graduate of the “Ecole Nationale Vétérinaire” in Nantes and of the “Institut d’Administration des Entreprises” in Montpellier. After practicing for a few years as a veterinarian, he joined Pfizer Animal Health where he held various positions in France and then in the United States. He joined Boehringer Ingelheim France in 2000 where he served first as Director of the Animal Health division then as Marketing Director for Human Health where he launched several major products for the company, particularly in cardiology and pulmonology. In 2007, he moved to the Boehringer Ingelheim Group headquarters in Germany where he held several positions in Human and Animal Health, including the role of Corporate Vice-President Business Analysis, Human Pharma and then Corporate Vice-President for Animal Health Marketing worldwide. In January 2017, he became President of Boehringer Ingelheim Animal Health in France and then Chair of the Boehringer Ingelheim Group in France in 2019, with responsibility for Animal Health, Human Health, industrial sites, R&D sites, and support functions.
